Mersana Therapeutics
Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for patients fighting cancer.
159 employees · est. 2001 · Cambridge, United States
Mersana Therapeutics is the older company (2015 vs 2001); Mersana Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Abcuro, Inc | Mersana Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2015 | 2001 older |
| Headquarters | ||
| Headquarters | Not tracked yet | Cambridge, United States |
| Employees | ||
| Employees | 43 | 159 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series B | Acquired |
| Total Funding | ||
| Total Funding | $214.85M | $534.80M |
| Funding Rounds | ||
| Funding Rounds | 5 | 13 |
| Services | ||
| Services | Not tracked yet | Drug Development, Clinical Trials, Patient Resource Support |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with cancer, Healthcare providers, Pharmaceutical partners, Researchers |
| Taxonomy | ||
| Taxonomy | Immunotherapy, Autoimmune Diseases, Cancer Treatments, Clinical Stage, Anti-KLRG1 Antibody, Orphan Drug Designation, Tumor Microenvironment, Bioinformatics, Transcriptome Analysis, Immune-modulatory Bio-therapeutics, Target Validation, Clinical Insights, Cytotoxic T Cells, NK Cells | Antibody-Drug Conjugates (ADCs), Cancer Research, Oncology Drug Development, Bioconjugation, Cytotoxic Therapeutics, Immunostimulatory Therapeutics, Biodegradable Polymer Platform, B7-H4 Targeting, HER2 Targeting, Clinical-Stage Biopharmaceuticals |
| Website | ||
| Website | abcuro.com | mersana.com |
About Abcuro, Inc
Abcuro, Inc is a clinical stage biotechnology company founded in 2015 that focuses on developing immunotherapies for autoimmune diseases and cancer. The company is known for its flagship products ABC008 and ABC015, both of which target cytotoxic T and NK cells expressing the inhibitory immune checkp...
About Mersana Therapeutics
Mersana Therapeutics, founded in 2001, is a visionary player in the Biotechnology and Health Care sectors, headquartered in the United States. With its mission, "Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for patients fighting cancer," the company stands at...
We will tell you when either one moves
BounceWatch watches Abcuro, Inc and Mersana Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Abcuro, Inc and Mersana Therapeutics — by email.
Frequently Asked Questions
Compare Abcuro, Inc with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Abcuro, Inc on 11 Sep 2024, and Mersana Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.